Anterior cruciate ligament (ACL) injuries constitute a significant portion of major knee joint injuries sustained by young, active individuals, and significantly increase risk for long-term disability. Yet the recommended solution to restore joint stability following injury--ACL reconstruction (ACLR)--does not prevent post-traumatic knee osteoarthritis (PTOA). Post-traumatic quadriceps (dys)function is a hallmark characteristic following ACLR, reported to accelerate the onset of PTOA after ACL injury, making the recovery of muscle function a primary concern to clinicians. However, hamstrings muscle function is drastically underrepresented relative to the quadriceps in the context of recovery from ACLR, which impedes the ability to develop targeted treatment approaches. Persistent hamstrings weakness is widely reported in patients who undergo ACLR with a hamstring tendon (HT) autograft, which increases ACL strain, and may contribute to higher graft failure rates in this population. To effectively treat muscular impairments, underlying neuromuscular adaptations known to occur in response to ACLR must be targeted. Eccentric exercise is uniquely suited to enhance neuromuscular function. The Nordic hamstring exercise (NHE) is a specific form of eccentric exercise that is clinically relevant and easy to implement, but has not been explored as an intervention for hamstrings neuromuscular dysfunction in patients who undergo ACLR with HT. To establish an evidence-based treatment model, the investigators will use a single-blind, randomized controlled clinical trial to establish the feasibility and efficacy of a 4-week NHE protocol in patients who undergo ACLR with HT. Separate factorial ANOVAs will be used to assess the effects of group (NHE, control) and time (baseline, 4 weeks) on selected outcomes. Effect sizes will be calculated for within- and between-group comparisons. The investigators expect to observe improvements in hamstrings neuromuscular function following the NHE protocol, and that those improvements will be greater than the control group. Additionally, the investigators expect the protocol to be feasible in terms of intervention adherence and patient retention. This study will identify specific barriers to the implementation of NHE in patients who undergo ACLR with HT, and will provide support for the application of an easy to implement clinical intervention able to address a complex neurophysiological problem.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Enrollment
23
A 4-week (10 session), progressive, NHE protocol will be used for this study. Immediately following the completion of study visit 1, patients will be informed about the nature of the NHE protocol. Those available and willing to participate will be randomized to an intervention group (NHE, control). Patients randomized to NHE will receive formal instruction about how to correctly perform the exercise, and will be asked to perform several repetitions to familiarize themselves with the exercise and verify proper technique. At this time, patients will be dismissed from study visit 1, and return visits 2-11 will be scheduled to complete the NHE protocol. Patients will return for a final study visit (12) to record post-intervention measurements within 7 days of completing the NHE protocol. A minimum of 48 hours will be used to separate study visits. To accurately assess patients' ability to perform the NHE, all exercise will be performed on a NordBord Hamstring Testing System.
The University of Toledo
Toledo, Ohio, United States
Change in peak eccentric torque
Hamstrings
Time frame: Baseline, 4 weeks
Change in peak isometric torque
Hamstrings
Time frame: Baseline, 4 weeks
Change in peak isokinetic torque
Hamstrings
Time frame: Baseline, 4 weeks
Change in rate of torque development
Hamstrings
Time frame: Baseline, 4 weeks
Change in torque coefficient of variation
Hamstrings
Time frame: Baseline, 4 weeks
Change in central activation ratio
Hamstrings
Time frame: Baseline, 4 weeks
Change in single leg hop
Hop for distance
Time frame: Baseline, 4 weeks
Change in active motor threshold
Transcranial magnetic stimulation (TMS) derived outcome in semitendinosus
Time frame: Baseline, 4 weeks
Change in cortical silent period
Transcranial magnetic stimulation (TMS) derived outcome in semitendinosus
Time frame: Baseline, 4 weeks
Change in short-interval cortical inhibition
Transcranial magnetic stimulation (TMS) derived outcome in semitendinosus
Time frame: Baseline, 4 weeks
Change in intracortical facilitation
Transcranial magnetic stimulation (TMS) derived outcome in semitendinosus
Time frame: Baseline, 4 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.